Literature DB >> 25525135

Inflammatory, immunological, and intestinal disease biomarkers in Chinese Shar-Pei dogs with marked hypocobalaminemia.

Niels Grützner1, Romy M Heilmann2, Shannon M Cranford2, Andreas Holzenburg2, Jan S Suchodolski2, Jörg M Steiner2.   

Abstract

Chinese Shar-Pei dogs have a high prevalence of hypocobalaminemia and are commonly presented with clinical signs suggestive of severe and long-standing gastrointestinal disease such as diarrhea, vomiting, and/or weight loss. The aim of the current study was to evaluate serum concentrations of inflammatory markers, markers for intestinal disease, and immunological markers in Shar-Peis with hypocobalaminemia or normocobalaminemia (serum cobalamin concentrations within the reference interval). Serum samples from Shar-Peis were collected from various parts of the United States. Serum concentrations of inflammatory markers (i.e., C-reactive protein [CRP], calprotectin [CP], and S100A12), hyaluronic acid (HA, a marker for cutaneous mucinosis), and analytes commonly altered in chronic intestinal diseases (i.e., albumin, zinc, alpha1-proteinease inhibitor [α1PI], immunoglobulin [Ig]A, and IgM) were compared between Shar-Peis with hypocobalaminemia and Shar-Peis with normocobalaminemia. Serum concentrations of CRP, CP, S100A12, HA, zinc, and cα1-PI concentrations did not differ between hypocobalaminemic and normocobalaminemic Shar-Peis (P > 0.05). Serum concentrations of albumin were significantly lower in hypocobalaminemic Shar-Peis (median: 2.5 g/dl) than in normocobalaminemic Shar-Peis (median: 2.9 g/dl; P < 0.0001). Higher serum IgA concentrations and lower serum IgM concentrations were observed in hypocobalaminemic Shar-Peis (median: 1.7 g/l and 0.8 g/l, respectively) than in normocobalaminemic Shar-Peis (median: 0.7 g/l and 1.9 g/l, respectively; both P < 0.0001). In conclusion, no difference was found in serum concentrations of CRP, CP, S100A12, and HA between hypocobalaminemic and normocobalaminemic Shar-Peis whereas some differences were observed in analytes (e.g., albumin, IgA, and IgM) that may be altered in patients with chronic enteropathies.
© 2014 The Author(s).

Entities:  

Keywords:  Chinese Shar-Pei dogs; hypocobalaminemia; inflammatory markers

Mesh:

Substances:

Year:  2015        PMID: 25525135     DOI: 10.1177/1040638714560881

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  7 in total

1.  Evaluation of hyaluronic acid, procollagen type III N-terminal peptide, and tissue inhibitor of matrix metalloproteinase-1 as serum markers of canine hepatic fibrosis.

Authors:  Jonathan A Lidbury; Aline Rodrigues Hoffmann; Joanna K Fry; Jan S Suchodolski; Jörg M Steiner
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

2.  An initial genome-wide investigation of protein-losing enteropathy in Gordon setters: Exploratory observations.

Authors:  Elle K Donnini; Muhammed Walugembe; Max F Rothschild; Albert E Jergens; Karin Allenspach
Journal:  Can J Vet Res       Date:  2021-01       Impact factor: 1.310

3.  Zinc Concentration in Blood Serum of Healthy Dogs.

Authors:  Viola Zentrichová; Alena Pechová; Simona Kovaříková
Journal:  Biol Trace Elem Res       Date:  2022-10-13       Impact factor: 4.081

4.  Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease.

Authors:  Cristiane C Otoni; Romy M Heilmann; Mercedes García-Sancho; Angel Sainz; Mark R Ackermann; Jan S Suchodolski; Jörg M Steiner; Albert E Jergens
Journal:  J Vet Intern Med       Date:  2018-04-06       Impact factor: 3.333

Review 5.  Review of cobalamin status and disorders of cobalamin metabolism in dogs.

Authors:  Stefanie Kather; Niels Grützner; Peter H Kook; Franziska Dengler; Romy M Heilmann
Journal:  J Vet Intern Med       Date:  2019-11-23       Impact factor: 3.333

6.  Decreased serum zinc concentration in dogs with lymphocytic-plasmacytic enteritis, and its associations with disease severity and prognosis.

Authors:  Kosei Sakai; Shingo Hatoya; Masaru Furuya; Shunsuke Shimamura; Tomoyo Nabetani; Hiroyuki Tani; Terumasa Shimada
Journal:  J Vet Med Sci       Date:  2020-04-16       Impact factor: 1.267

Review 7.  Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs.

Authors:  Romy M Heilmann; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2018-09-17       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.